Dyno Nobel (ASX:DNL): Explosives Performance, Fertilisers Exit and Autonomous Blasting

Aditi Sarkar

26 October 2026 04:54 PM AEDT

Dyno Nobel (ASX:DNL): Explosives Performance, Fertilisers Exit and Autonomous Blasting

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Dyno Nobel (ASX:DNL) reported 1H26 EBIT excluding individually material items of AUD 242.7mn, up 39.3% YoY.
Continuing-operations revenue increased to AUD 1,609.8mn in 1H26.
The Phosphate Hill fertilisers business sale completed in June 2026.
An autonomous blast-hole loading system is scheduled for staged trials through mid-2027.

Dyno Nobel Limited supplies commercial explosives, blasting systems and technical services to mining and quarrying customers across several regions. At the time of writing on 26 October 2026, Dyno Nobel (ASX:DNL) was trading at AUD 3.84, down 0.26% during the session. Its recent disclosures cover the completed exit from fertilisers manufacturing, changes in earnings from its explosives operations and development of autonomous drill-and-blast technology.

Company Business

Dyno Nobel (ASX:DNL) manufactures and supplies bulk explosives, initiating systems and related blasting services. Its reporting structure comprises Dyno Nobel Asia Pacific (DNAP), Dyno Nobel Americas (DNA) and Dyno Nobel EMEA and Latin America (DNEL). Operations serve mines and other customers that require controlled rock fragmentation, with activities spanning manufacturing, distribution, technical support and blasting technology.

The company has been reshaping its portfolio around the explosives business. Its products and consulting services are exposed to customer mining activity, plant reliability, raw-material costs, regulation and the timing of mine development and production schedules. Its business mix also includes technology intended to automate activities traditionally performed on blast benches.

Recent Development

On 1 July 2026, Dyno Nobel (ASX:DNL) announced completion of the Phosphate Hill sale, effective 30 June. The transaction included a fixed AUD 50mn completion contribution, deferred consideration of AUD 150mn subject to conditions and AUD 125.9mn of funding linked to future remediation obligations. The buyer assumed operational and environmental liabilities from completion. The disposal followed the earlier separation of fertilisers distribution and other activities.

In September 2026, the group presented its technology priorities at an investor event. A subsequent announcement described a developed prototype for an autonomous bench system that can inspect, prime, load, stem and record blast holes. The company outlined initial trials at a Utah mine and a staged development path through mid-2027. Commercial deployment and customer adoption remain distinct from the prototype announcement.

Financial Performance and Sector Context

For the half-year ended 31 March 2026, Dyno Nobel (ASX:DNL) recorded group revenue of AUD 1,897.8mn, compared with AUD 2,250.7mn in 1H25, reflecting its changing portfolio. Revenue from continuing operations rose to AUD 1,609.8mn from approximately AUD 1,473.0mn. Group EBITDA excluding individually material items increased 17.2% YoY to AUD 378.0mn, while EBIT on the same basis rose 39.3% YoY to AUD 242.7mn.

Net profit after tax excluding individually material items was AUD 160.9mn, compared with AUD 87.8mn in 1H25. Statutory net profit attributable to shareholders was AUD 19.9mn, after AUD 141.0mn of individually material items, largely related to impairment and exit costs. The result illustrates the distinction between continuing operating performance and expenses associated with the portfolio transition.

DNAP recorded EBIT of AUD 130mn, up 16% YoY, and DNA delivered AUD 101mn, up 42% YoY. DNEL EBIT was AUD 9mn, down 29% YoY, with the prior period including non-recurring asset-sale gains. The group reaffirmed FY26 explosives EBIT guidance of approximately AUD 460mn–500mn in its May update. Mining demand, manufacturing availability, foreign exchange and energy inputs remain relevant operating variables.

Risks to Consider

Dyno Nobel (ASX:DNL) remains exposed to industrial safety incidents, manufacturing disruptions and commodity-linked customer demand. Input costs and currency changes can affect segment margins. The fertilisers exit carries deferred consideration and remediation-related arrangements, while execution of restructuring initiatives may influence expenses. New automation products also face engineering, trial, regulatory and customer-adoption risks.

What to Watch Next

Monitoring points for Dyno Nobel (ASX:DNL) include the FY26 results, progress against explosives EBIT guidance, regional segment earnings and further disclosures on portfolio-separation cash flows. Technical trial updates on the autonomous bench system, including performance at the initial US site, will show whether the prototype advances through its announced rollout stages.

Key Insights

Dyno Nobel reported higher 1H26 underlying earnings alongside a lower group revenue base following business disposals. Completion of the Phosphate Hill transaction refocused operations on explosives, while its autonomous loading initiative remains at the trial stage. Subsequent financial results and technology milestones will provide measurable updates on these changes.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.